BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 16476833)

  • 1. Interethnic differences in genetic polymorphisms of CYP2D6 in the U.S. population: clinical implications.
    Bernard S; Neville KA; Nguyen AT; Flockhart DA
    Oncologist; 2006 Feb; 11(2):126-35. PubMed ID: 16476833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
    Zhou SF; Liu JP; Chowbay B
    Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity.
    Ingelman-Sundberg M
    Pharmacogenomics J; 2005; 5(1):6-13. PubMed ID: 15492763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytochrome P450 CYP2D6.
    Wolf CR; Smith G
    IARC Sci Publ; 1999; (148):209-29. PubMed ID: 10493260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology, pharmacogenetics, and clinical efficacy of 5-hydroxytryptamine type 3 receptor antagonists for postoperative nausea and vomiting.
    Ho KY; Gan TJ
    Curr Opin Anaesthesiol; 2006 Dec; 19(6):606-11. PubMed ID: 17093363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a PCR-based strategy for CYP2D6 genotyping including gene multiplication of worldwide potential use.
    Dorado P; Cáceres MC; Pozo-Guisado E; Wong ML; Licinio J; Llerena A
    Biotechniques; 2005 Oct; 39(4):571-4. PubMed ID: 16235570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical pharmacogenetics in the treatment of schizophrenia].
    Saito M; Yasui-Furukori N; Kaneko S
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2005 Jun; 25(3):129-35. PubMed ID: 16045195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochrome P450 2D6 metabolism and 5-hydroxytryptamine type 3 receptor antagonists for postoperative nausea and vomiting.
    Janicki PK
    Med Sci Monit; 2005 Oct; 11(10):RA322-8. PubMed ID: 16192915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of single nucleotide polymorphisms of CYP2D6 in the Czech population.
    Buzková H; Pechandová K; Slanar O; Perlík F
    Cell Biochem Funct; 2008; 26(1):76-81. PubMed ID: 17311358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetics: has it reached the clinic?
    Schwartz JB
    J Gend Specif Med; 2002; 5(2):13-8. PubMed ID: 11974670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical importance of genetic polymorphism of drug oxidation.
    Edeki T
    Mt Sinai J Med; 1996; 63(5-6):291-300. PubMed ID: 8898530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional characterization of 17 CYP2D6 allelic variants (CYP2D6.2, 10, 14A-B, 18, 27, 36, 39, 47-51, 53-55, and 57).
    Sakuyama K; Sasaki T; Ujiie S; Obata K; Mizugaki M; Ishikawa M; Hiratsuka M
    Drug Metab Dispos; 2008 Dec; 36(12):2460-7. PubMed ID: 18784265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetics in breast cancer therapy.
    Tan SH; Lee SC; Goh BC; Wong J
    Clin Cancer Res; 2008 Dec; 14(24):8027-41. PubMed ID: 19088019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYP2D6*4 polymorphism is associated with statin-induced muscle effects.
    Frudakis TN; Thomas MJ; Ginjupalli SN; Handelin B; Gabriel R; Gomez HJ
    Pharmacogenet Genomics; 2007 Sep; 17(9):695-707. PubMed ID: 17700359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetics of antipsychoatics.
    Ozaki N
    Nagoya J Med Sci; 2004 May; 67(1-2):1-7. PubMed ID: 15279062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic polymorphisms of CYP2D6 in Chinese mainland.
    Ji L; Pan S; Wu J; Marti-Jaun J; Hersberger M
    Chin Med J (Engl); 2002 Dec; 115(12):1780-4. PubMed ID: 12622923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of CYP2D6 polymorphisms and tamoxifen in women with breast cancer.
    Gaston C; Kolesar J
    Clin Adv Hematol Oncol; 2008 Nov; 6(11):825-33. PubMed ID: 19194367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complexities of CYP2D6 gene analysis and interpretation.
    Gaedigk A
    Int Rev Psychiatry; 2013 Oct; 25(5):534-53. PubMed ID: 24151800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenomics in Alzheimer's disease.
    Cacabelos R
    Methods Mol Biol; 2008; 448():213-357. PubMed ID: 18370236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of CYP2D6 polymorphisms on dextromethorphan metabolism in Mexican Americans.
    Casner PR
    J Clin Pharmacol; 2005 Nov; 45(11):1230-5. PubMed ID: 16239355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.